A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: the SYNTAX Trial at 3 years.

Explore this paper's citation graph

Summary

Risk-model performance and reclassification analyses demonstrated that the EuroSCORE-with the added incremental benefit of the SXscore to form the Global Risk-enhanced the risk stratification of all PCI patients.

Type
article
Published
2012-06-01
Cited by
101
References
58
Access
Open access

Keywords

Conventional PCI, Percutaneous coronary intervention, Medicine, Cardiology, Internal medicine

References

Cited by

Related papers